Immune checkpoint inhibitors have revolutionized cancer treatment, but their effectiveness is limited by the immune status of the patient. In many cases, patients with immunologically cold ...

An international team of researchers led by scientists at Iowa State University, Weill Cornell Medicine and Children's Hospital of Philadelphia (CHOP) has found that an orphan gene in the SARS-CoV-2 ...

This week, I'm turning my column over to Jonathan Karn, PhD, Professor and Chair, Department of Molecular Biology and Microbiology, and Director, Case Center for AIDS Research. Many people would like ...

In a quest to develop new antiviral drugs for COVID-19 and other diseases, a collaboration led by scientists at The Wertheim UF Scripps Institute has identified a potential new drug against the virus ...

A multi-institutional team led by University of Washington scientists have engineered a new vaccine platform combining mRNA ...

MERS-CoV is one of three major coronaviruses—alongside SARS-CoV and SARS-CoV-2—that have emerged in the past two decades with ...

Nearly 80% of adults with a previous SARS-CoV-2 infection demonstrated a loss of smell up to 2 years later, according to a ...

Researchers in Spain and Argentina have developed a ring-shaped protein nanomaterial that binds to and neutralises SARS-CoV-2 ...

Research reveals a sharp decline in both the effectiveness and duration of protection from prior infection post-Omicron, underscoring the need for updated vaccines to sustain immunity Study: ...

The trial, led by Professor Robert Bals, Director of the Department of Internal Medicine V at Saarland University Medical Center and Professor of Internal Medicine at Saarland University, divided the ...